NOTICE OF ALLOWANCE - ISSUED
issued
on 23 Jan 2024
Last Applicant/ Owned by
60 Leveroni Court
Novato
CA
94949
Serial Number
97822923 filed on 03rd Mar 2023
Registration Number
N/A
Correspondent Address
Anne H. Peck COOLEY LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
GENGLYCOS
Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to reg Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare metabolic and genetic diseases and disorders
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical, scientific, and medical research, namely, compiling and sharing of patient data for research purposes in the field of metabolic and rare metabolic and genetic diseases and disorders; providing medical and scientific research information in the field of metabolic and rare metabolic and genetic diseases and disorders
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Mark Details
Serial Number
No 97822923
Mark Type
No Service Mark
Attorney Docket Number
No 315613-20000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th May 2024 | SOU TEAS EXTENSION RECEIVED |
| 23rd Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 28th Nov 2023 | PUBLISHED FOR OPPOSITION |
| 28th Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Nov 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 25th Oct 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Oct 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 24th Oct 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 24th Oct 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 24th Sep 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |